Finance

Lists
Why is 002275 up 10.00%?
Dive Deeper
002275:SHE
Guilin Sanjin Pharmaceutical Co., Ltd.
CNÂ¥17.38
+10.00%
(+1.58) 1D
Nov 4, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002275...
Open
CNÂ¥15.80
High
CNÂ¥17.38
Low
CNÂ¥15.12
Mkt. cap
9.28B
Avg. vol.
5.44M
Volume
41.17M
Dividend
2.88%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 4, 2026
P/E ratio
24.18
52-wk high
CNÂ¥17.38
52-wk low
CNÂ¥11.82
EPS
CNÂ¥0.72
Shares outstanding
587.57M
No. of employees
3K
Open
CNÂ¥15.80
High
CNÂ¥17.38
Low
CNÂ¥15.12
Mkt. cap
9.28B
Avg. vol.
5.44M
Volume
41.17M
Dividend
2.88%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 4, 2026
P/E ratio
24.18
52-wk high
CNÂ¥17.38
52-wk low
CNÂ¥11.82
EPS
CNÂ¥0.72
Shares outstanding
587.57M
No. of employees
3K
News stories
From web sources and news partners
About Guilin Sanjin Pharmaceutical Co., Ltd.
CEO-
Employees2.56K
FoundedFeb 23, 1994
Headquarters-
SectorPharmaceutical industry
Industry-
Websitesanjin.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
583.35M
525.12M
443.48M
475.45M
Cost of goods sold
146.29M
93.13M
145.58M
117.25M
Cost of revenue
146.29M
93.13M
145.58M
117.25M
Research and development expenses
68.98M
53.24M
10.16M
16.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
270.13M
185.28M
122.37M
187.31M
Operating expense
354.02M
284.20M
152.34M
149.71M
Total operating expenses
500.30M
377.33M
297.92M
266.96M
Operating income
83.04M
147.79M
145.56M
208.49M
Other non operating income
1.46M
-151.83K
-496.00
-41.21M
EBT including unusual items
67.38M
152.08M
161.91M
136.60M
EBT excluding unusual items
74.31M
150.90M
149.82M
159.74M
Income tax expense
19.47M
27.73M
25.60M
22.92M
Effective tax rate
28.90%
18.23%
15.81%
16.78%
Other operating expenses
1.60M
1.07M
15.00M
-5.17M
Net income
47.91M
124.36M
136.31M
113.68M
Net profit margin
8.21%
23.68%
30.74%
23.91%
Earnings per share
-
-
-
-
Interest and investment income
6.17M
4.23M
9.11M
5.90M
Interest expense
-16.71M
-971.70K
-4.93M
-13.34M
Net interest expenses
-10.54M
3.26M
4.18M
-7.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
103.95M
168.69M
166.41M
229.39M
Gain or loss from assets sale
-145.62K
-
-8.06K
8.06K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps